J9265 – Injection, paclitaxel, 30 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9265
- Long description
- Injection, paclitaxel, 30 mg
- Short description
- Paclitaxel injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 1994
- Last change
- January 1, 2015 – No change
- Termination date
- December 31, 2014
Frequently asked questions
What is HCPCS code J9265?
J9265 is a HCPCS Level II code for injection, paclitaxel, 30 mg. It was discontinued on December 31, 2014.
Does Medicare cover J9265?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9256 – Injection, nipocalimab-aahu, 3 mg
- J9258 – Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg
- J9259 – Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg
- J9260 – Injection, methotrexate sodium, 50 mg
- J9261 – Injection, nelarabine, 50 mg
- J9262 – Injection, omacetaxine mepesuccinate, 0.01 mg
- J9263 – Injection, oxaliplatin, 0.5 mg
- J9264 – Injection, paclitaxel protein-bound particles, 1 mg
- J9266 – Injection, pegaspargase, per single dose vial
- J9267 – Injection, paclitaxel, 1 mg
- J9268 – Injection, pentostatin, 10 mg
- J9269 – Injection, tagraxofusp-erzs, 10 micrograms
- J9270 – Injection, plicamycin, 2.5 mg
- J9271 – Injection, pembrolizumab, 1 mg
- J9272 – Injection, dostarlimab-gxly, 10 mg
- J9273 – Injection, tisotumab vedotin-tftv, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.